Is this you? Create Your Porfile
Avatar

Michael J. Konkel

Lundbeck

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael J. Konkel is active.

Explore More

Publication

Featured researches published by Michael J. Konkel.

Proceedings of the National Academy of Sciences of the United States of America | 2005

Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299

Chad J. Swanson; Thomas P. Blackburn; Xuexiang Zhang; Kang Zheng; Zhi-Qing David Xu; Tomas Hökfelt; Toni D. Wolinsky; Michael J. Konkel; Heidi Chen; Huailing Zhong; Mary W. Walker; Douglas A. Craig; Christophe Gerald; Theresa Branchek

Journal of Medicinal Chemistry | 2006

3-arylimino-2-indolones are potent and selective galanin GAL3receptor antagonists

Michael J. Konkel; Bharat Lagu; Lakmal W. Boteju; Hermogenes N. Jimenez; Stewart A. Noble; Mary W. Walker; Gamini Chandrasena; Thomas P. Blackburn; Sham S. Nikam; Jon Wright; Brian Edward Kornberg; Tracy Fay Gregory; Thomas A. Pugsley; Hyacinth Akunne; Kim Zoski; Lawrence D. Wise

Bioorganic & Medicinal Chemistry Letters | 2006

Amino substituted analogs of 1-phenyl-3-phenylimino-2-indolones with potent galanin Gal3 receptor binding affinity and improved solubility

Michael J. Konkel; Mathivanan Packiarajan; Heidi Chen; Upendra Topiwala; Hermogenes N. Jimenez; Ian Jamie Talisman; Heather Renee Coate; Mary W. Walker

Archive | 2002

Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods

Michael J. Konkel; John M. Werzel; Jamie Talisman

Journal of Medicinal Chemistry | 2005

Synthesis and Structure−Activity Relationship of Fluoro Analogues of 8-{2-[4-(4-Methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as Selective α1d-Adrenergic Receptor Antagonists

Michael J. Konkel; John M. Wetzel; Marie Cahir; Douglas A. Craig; Stewart A. Noble; Charles Gluchowski

Archive | 2005

3-imino-2-indolones for the treatment of depression and/or anxiety

Michael J. Konkel; John M. Wetzel; Jamie Talisman

Archive | 2003

Use of GAL3 antagonist for treatment of depression

Thomas P. Blackburn; Michael J. Konkel; Lakmal W. Boteju; Ian Jamie Talisman; John M. Wetzel; Mathivana Packiarajan; Heidi Chen; Hermo Jimenez

Archive | 2001

Compounds specific for the human alpha1d adrenergic receptor and uses thereof

Michael J. Konkel; John M. Wetzel; Stewart A. Noble; Charles Gluchowski; Douglas A. Craig

Archive | 2002

Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors

Joel K. Kawakami; John M. Wetzel; Lakmal W. Boteju; Michael J. Konkel; Honghe Wan; Stewart A. Noble

Archive | 2004

GAL3 receptor antagonists for the treatment of affective disorders

Michael J. Konkel; Thomas P. Blackburn; John M. Wetzel

Explore More

Collaboration

Dive into the Michael J. Konkel's collaboration.

Top Co-Authors
Avatar

John M. Wetzel

New York University

View shared research outputs
Top Co-Authors
Avatar

Heidi Chen

Lundbeck

View shared research outputs
Top Co-Authors
Avatar

Lakmal W. Boteju

University of Arizona

View shared research outputs
Top Co-Authors
Avatar

Stewart A. Noble

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Ian Jamie Talisman

Lundbeck

View shared research outputs
Top Co-Authors
Avatar

Thomas P. Blackburn

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Mathivanan Packiarajan

Lundbeck

View shared research outputs
Top Co-Authors
Avatar

Bharat Lagu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Douglas A. Craig

Lundbeck

View shared research outputs
Top Co-Authors
Avatar

Hermogenes N. Jimenez

Lundbeck

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge